2019-01-07 | Sale | Intra-Cellular Therapies, Inc. ITCI | SVP, Early Stage Clinical Dev. | 1,184 0.0021% | $12.29 | $14,551 | -3.63% | |
2019-01-04 | Sale | Intra-Cellular Therapies, Inc. ITCI | SVP, Early Stage Clinical Dev. | 19,128 0.0335% | $11.47 | $219,407 | +1.35% | |
2019-01-02 | Sale | Intra-Cellular Therapies, Inc. ITCI | SVP, Early Stage Clinical Dev. | 9,668 0.0169% | $11.10 | $107,315 | +4.34% | |
2018-01-08 | Sale | Intra-Cellular Therapies, Inc. ITCI | SVP, Clinical Development | 1,544 0.0028% | $17.46 | $26,958 | +12.37% | |
2018-01-05 | Sale | Intra-Cellular Therapies, Inc. ITCI | SVP, Clinical Development | 2,370 0.0043% | $17.37 | $41,167 | +12.34% | |
2017-01-05 | Sale | Intra-Cellular Therapies, Inc. ITCI | SVP, Clinical Development | 1,600 0.0037% | $16.59 | $26,544 | -14.43% | |
2016-12-15 | Sale | Intra-Cellular Therapies, Inc. ITCI | SVP, Clinical Development | 18,750 0.0311% | $11.54 | $216,373 | -11.61% |